The information contained in this section of the site is intended for US healthcare professionals only. Please click the appropriate link below.
Not actual patients. Results may vary.
Designed to give you complete clearance
KLISYRI® is a novel treatment for actinic keratosis (AK)
KLISYRI® was studied in the largest AK clinical trial program of its kind*
In these studies, 4x to 9x more KLISYRI® patients achieved complete 100% clearance than did placebo patients
*
The largest pivotal clinical trial program of an AK topical prescription treatment.
Designed to meet your lifestyle needs
KLISYRI® is the shortest topical prescription treatment available for AK today—only 5 days. In clinical studies, 99% of patients stayed on KLISYRI® treatment for the full 5 days. No reactions due to sun exposure occurred in healthy patients who were using KLISYRI®†
†
Clinical studies in healthy subjects demonstrated KLISYRI® did not cause contact sensitization, phototoxic skin reactions, or photoallergic skin reactions.
Skin reactions with KLISYRI® were mostly mild to moderate
In clinical trials, the most common side effects with KLISYRI® were local skin reactions, including itching and pain in the treatment area
In these clinical trials, fewer than 1 in 10 patients had severe local skin reactions
Local skin reactions can also be severe in treatment with KLISYRI®
Call your healthcare provider if you develop any local skin reactions, including redness, flaking or scaling, crusting, or swelling that is more severe, or if you get blisters, peeling, pus, ulcers, or breakdown of your skin
Skin reactions to KLISYRI® treatment
(Resolution over time)
In these studies, a total of 702 patients were monitored for development of skin reactions on day 8 following 5-day treatment with KLISYRI®, and then on days 15, 29, and 57. Skin reactions peaked at day 8 and resolved by day 29
KLISYRI® is convenient to use
Available in convenient, disposable, single-use packs
Do not use more KLISYRI® than you need to cover the treatment area
Using too much KLISYRI®, or using it too often, or for too long can increase your chances of having a severe skin reaction or other side effects
Do not get KLISYRI® in, around, or near your eyes
Do not touch your eyes while you are applying KLISYRI®
Do not get KLISYRI® in, around, or near your mouth or lips
Please see additional information in the How should I use KLISYRI®? section below
Designed to make treatment affordable
Save on your prescription through Almirall Advantage‡
If you have commercial (nongovernment) coverage, you may be able to pay as little as $25 for your KLISYRI® prescription
Take advantage of the KLISYRI®
Comprehensive Specialty Pharmacy Network
Save on your KLISYRI® prescription costs through a licensed pharmacy that can ship directly to you
Access the KLISYRI® co-pay card
‡
Eligible patients with commercial (nongovernment) insurance only. Terms and conditions apply. Current as of April 3, 2023. Coverage is subject to change. Patients may pay as little as $25 if covered by insurance and $95 if not covered.
Designed to support your treatment needs
Download helpful information about AK and treatment with KLISYRI®, including how to apply.
AK: actinic keratosis.
Important: KLISYRI is for use on the skin only (topical). Do not use KLISYRI in, around, or near your eyes, mouth or lips.
KLISYRI is a prescription medicine used on the skin to treat actinic
keratosis on the face or scalp.
It is not known if KLISYRI is safe and effective in children less
than 18 years of age.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
KLISYRI may cause serious side effects, including:
The most common side effects of KLISYRI include: itching or pain in the treatment area.
These are not all of the possible side effects of KLISYRI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see Patient Information and full Prescribing Information.
Important: KLISYRI is for use on the skin only (topical). Do not use KLISYRI in, around, or near your eyes, mouth or lips.
KLISYRI is a prescription medicine used on the skin to treat actinic
keratosis on the face or scalp.
It is not known if KLISYRI is safe and effective in children less
than 18 years of age.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements.
KLISYRI may cause serious side effects, including:
The most common side effects of KLISYRI include: itching or pain in the treatment area.
These are not all of the possible side effects of KLISYRI. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see Patient Information and full Prescribing Information.